Snowden Capital Advisors LLC Xenon Pharmaceuticals Inc. Transaction History

Snowden Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $435 - $525	12 Added 0.22%	5,511 $214,000
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $9,555 - $11,208	-224 Reduced 3.91%	5,499 $236,000
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $4,075 - $6,597	-142 Reduced 2.42%	5,723 $263,000
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $4,474 - $5,204	-131 Reduced 2.18%	5,865 $200,000
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $208,900 - $261,065	5,996 New	5,996 $230,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.